Results 201 to 210 of about 93,748 (310)

Sodium glucose co‐transporter 2 inhibitors versus dipeptidyl peptidase‐4 inhibitors and the risk of ventricular arrhythmia among patients with type 2 diabetes: A population‐based cohort study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To determine whether sodium glucose co‐transporter 2 inhibitors (SGLT2i) use, compared with dipeptidyl peptidase‐4 inhibitors (DPP4i) use, is associated with the risk of ventricular arrhythmias (VA) among patients with type 2 diabetes. Materials and Methods We conducted a population‐based cohort study using a prevalent new‐user design and
Wang‐Choi Tang, Pauline Reynier, Antonios Douros, Oriana H. Y. Yu, Robert W. Platt, Kristian B. Filion   +5 more
wiley   +1 more source

Comparative efficacy of different antihypertensive drug classes for stroke prevention: A network meta-analysis of randomized controlled trials. [PDF]

PLoS One
Yu D, Li JX, Cheng Y, Wang HD, Ma XD, Ding T, Zhu ZN.   +6 more
europepmc   +1 more source

Antihypertensive and Antidiabetic Drug Candidates from Milkfish (Chanos chanos)—Identification and Characterization through an Integrated Bioinformatic Approach

Roni Nugraha, Fahmi Kurniawan, Asadatun Abdullah, Andreas L. Lopata, Thimo Ruethers   +4 more
openalex   +1 more source

One‐year usage patterns of SGLT‐2 inhibitors and GLP‐1 receptor agonists in individuals with type 2 diabetes in a real‐world population

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Real‐world studies of sodium‐glucose co‐transporter‐2 inhibitors (SGLT2i) and glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) typically assess adherence and discontinuation as separate outcomes. We applied a novel approach that integrates these measures to categorize patterns of drug usage.
Louise A. Donnelly, Katyayeni Singh, Rory J. McCrimmon, Ewan R. Pearson   +3 more
wiley   +1 more source

Guanabenz acetate, an antihypertensive drug repurposed as an inhibitor of <i>Escherichia coli</i> biofilm. [PDF]

Microbiol Spectr
Farha AK, Habimana O, Corke H.
europepmc   +1 more source

Clinical Study on the Effects of Antihypertensive Drugs

, 1973
Rin Chang, Sung Ho Lee
openalex   +1 more source

SGLT2 inhibitor or metformin as standard treatment in early‐stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register‐based randomised trial on prevention of diabetic complications

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Metformin has hitherto not been proven superior to other type 2 diabetes (T2D) medications for the prevention of organ complications. The aim of this study is to report baseline data and blinded interim analyses in the register‐based randomised clinical trial (RRCT) SMARTEST, which compares metformin and the SGLT2 inhibitor dapagliflozin ...
Jan W. Eriksson, Giovanni Fanni, Martin H. Lundqvist, Stefan Jansson, Karin Rådholm, Sheyda Sofizadeh, Vagia Patsoukaki, Albert Nilsson, Daniel Lindholm, Olov Rolandsson, Anna Norhammar, Elisabet Granstam, Björn Eliasson, Louise Bennet, Johan Sundström   +14 more
wiley   +1 more source

Effect of different single and combined antihypertensive drug regimens on the mortality of critical care patients. [PDF]

Front Pharmacol
Fang Y, Huang X, Shi J, Ren C, Zhang X.
europepmc   +1 more source

Treatment of hypertensive patients with mebutamate, a new antihypertensive drug. A preliminary study.

, 1962
John L. S. Holloman
openalex   +2 more sources

Unintentional periconceptional exposure to glucagon‐like peptide‐1 receptor agonists and adverse pregnancy outcomes: A nationwide cohort study in Taiwan

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess whether periconceptional exposure to glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) is associated with adverse outcomes in women with pregestational type 2 diabetes. Materials and Methods We linked Taiwan's Birth Certificate Application and National Health Insurance claims (2013–2022) to assemble a nationwide cohort of ...
Yi‐Chang Chou, Shih‐Han Weng, Feng‐Shiang Cheng, Chih‐Hao Tseng, Hsiao‐Yun Hu, Chieh‐Hsing Liu   +5 more
wiley   +1 more source